by Elizabeth Story, MD | Oct 21, 2025 | Blog
GLP-1 receptor agonists like semaglutide and tirzepatide have revolutionized weight loss and diabetes care. But a growing number of patients and clinicians are exploring microdosing—taking a fraction of the standard dose—to unlock broader health benefits with fewer...
